Cargando…
Bacterial endocarditis following COVID-19 infection: two case reports
BACKGROUND: COVID-19, an emerging disease raised as a pandemic, urgently needed treatment choices. Some options have been confirmed as lifesaving treatments, but long-term complications must be clearly illustrated. Bacterial endocarditis is a less frequent disease among patients infected with SARS_C...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273726/ https://www.ncbi.nlm.nih.gov/pubmed/37322551 http://dx.doi.org/10.1186/s13256-023-03970-6 |
_version_ | 1785059703908204544 |
---|---|
author | Barahimi, Elham Defaee, Sahar Shokraei, Rahele Sheybani-Arani, MohammadHosein Salimi Asl, Ali Ghaem, Hossein Montazer |
author_facet | Barahimi, Elham Defaee, Sahar Shokraei, Rahele Sheybani-Arani, MohammadHosein Salimi Asl, Ali Ghaem, Hossein Montazer |
author_sort | Barahimi, Elham |
collection | PubMed |
description | BACKGROUND: COVID-19, an emerging disease raised as a pandemic, urgently needed treatment choices. Some options have been confirmed as lifesaving treatments, but long-term complications must be clearly illustrated. Bacterial endocarditis is a less frequent disease among patients infected with SARS_COV_2 compared to other cardiac comorbidities in these patients. This case report discusses bacterial endocarditis as a potential adverse effect after administering tocilizumab, corticosteroids, and COVID-19 infection. CASE PRESENTATION: In the first case, a 51-year-old Iranian female housewife was admitted to the hospital with fever, weakness, and monoarthritis symptoms. The second case is a 63-year-old Iranian woman who is a housewife admitted with weakness, shortness of breath, and extreme sweating. Both cases tested positive for Polymerase chain reaction (PCR) less than one month ago and were treated with tocilizumab and corticosteroid. Both patients were suspected of infective endocarditis. Methicillin-resistant Staphylococcus aureus (MRSA) was detected in the blood cultures of both patients. The diagnosis of endocarditis is confirmed for both cases. Cases are subjected to open-heart surgery, a mechanical valve is placed, and they are treated with medication. In subsequent visits, their condition was reported to be improving. CONCLUSION: Adjacent to cardiovascular inclusion as COVID-19 disease complications, secondary infection taken after the organisation of immunocompromising specialists can result in basic maladies and conditions counting infective endocarditis. |
format | Online Article Text |
id | pubmed-10273726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102737262023-06-17 Bacterial endocarditis following COVID-19 infection: two case reports Barahimi, Elham Defaee, Sahar Shokraei, Rahele Sheybani-Arani, MohammadHosein Salimi Asl, Ali Ghaem, Hossein Montazer J Med Case Rep Case Report BACKGROUND: COVID-19, an emerging disease raised as a pandemic, urgently needed treatment choices. Some options have been confirmed as lifesaving treatments, but long-term complications must be clearly illustrated. Bacterial endocarditis is a less frequent disease among patients infected with SARS_COV_2 compared to other cardiac comorbidities in these patients. This case report discusses bacterial endocarditis as a potential adverse effect after administering tocilizumab, corticosteroids, and COVID-19 infection. CASE PRESENTATION: In the first case, a 51-year-old Iranian female housewife was admitted to the hospital with fever, weakness, and monoarthritis symptoms. The second case is a 63-year-old Iranian woman who is a housewife admitted with weakness, shortness of breath, and extreme sweating. Both cases tested positive for Polymerase chain reaction (PCR) less than one month ago and were treated with tocilizumab and corticosteroid. Both patients were suspected of infective endocarditis. Methicillin-resistant Staphylococcus aureus (MRSA) was detected in the blood cultures of both patients. The diagnosis of endocarditis is confirmed for both cases. Cases are subjected to open-heart surgery, a mechanical valve is placed, and they are treated with medication. In subsequent visits, their condition was reported to be improving. CONCLUSION: Adjacent to cardiovascular inclusion as COVID-19 disease complications, secondary infection taken after the organisation of immunocompromising specialists can result in basic maladies and conditions counting infective endocarditis. BioMed Central 2023-06-16 /pmc/articles/PMC10273726/ /pubmed/37322551 http://dx.doi.org/10.1186/s13256-023-03970-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Barahimi, Elham Defaee, Sahar Shokraei, Rahele Sheybani-Arani, MohammadHosein Salimi Asl, Ali Ghaem, Hossein Montazer Bacterial endocarditis following COVID-19 infection: two case reports |
title | Bacterial endocarditis following COVID-19 infection: two case reports |
title_full | Bacterial endocarditis following COVID-19 infection: two case reports |
title_fullStr | Bacterial endocarditis following COVID-19 infection: two case reports |
title_full_unstemmed | Bacterial endocarditis following COVID-19 infection: two case reports |
title_short | Bacterial endocarditis following COVID-19 infection: two case reports |
title_sort | bacterial endocarditis following covid-19 infection: two case reports |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273726/ https://www.ncbi.nlm.nih.gov/pubmed/37322551 http://dx.doi.org/10.1186/s13256-023-03970-6 |
work_keys_str_mv | AT barahimielham bacterialendocarditisfollowingcovid19infectiontwocasereports AT defaeesahar bacterialendocarditisfollowingcovid19infectiontwocasereports AT shokraeirahele bacterialendocarditisfollowingcovid19infectiontwocasereports AT sheybaniaranimohammadhosein bacterialendocarditisfollowingcovid19infectiontwocasereports AT salimiaslali bacterialendocarditisfollowingcovid19infectiontwocasereports AT ghaemhosseinmontazer bacterialendocarditisfollowingcovid19infectiontwocasereports |